SCHEMBL18178938

SCHEMBL18178938

COC(=S)Oc1cccc(C)c1COc1cc(C)c(C)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 3/20 0.41
MAPT P10636 2/20 0.40
RAB9A P51151 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
LMNA P02545 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
SGMS2 Q8NHU3 2/20 0.35
PTPN1 P18031 1/20 0.33
MRGPRX4 Q96LA9 3/20 0.32
KMT2A Q03164 2/20 0.32
HPGD P15428 1/20 0.32
MEN1 O00255 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA1D P25100 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18182667 0.89 SLC22A12 (0.40) SLC22A12MAPTRAB9ANPSR1LMNA
SCHEMBL18178941 0.88 MAPT (0.38) SLC22A12MAPTRAB9ANPSR1LMNA
SCHEMBL18178940 0.88 MAPT (0.38) SLC22A12MAPTRAB9ANPSR1LMNA
SCHEMBL18178946 0.88 MAPT (0.38) SLC22A12MAPTRAB9ANPSR1LMNA
SCHEMBL18178933 0.88 MRGPRX4 (0.38) SLC22A12MAPTRAB9ANPSR1LMNA
SCHEMBL18178934 0.88 NPSR1 (0.38) SLC22A12MAPTRAB9ANPSR1L3MBTL1
SCHEMBL18178937 0.87 MAPT (0.37) SLC22A12MAPTRAB9ANPSR1LMNA
SCHEMBL18178939 0.87 MAPT (0.39) SLC22A12MAPTRAB9ANPSR1LMNA
SCHEMBL18178816 0.87 MRGPRX4 (0.44) SLC22A12MAPTRAB9ALMNAL3MBTL1
SCHEMBL18178943 0.86 MAPT (0.36) SLC22A12MAPTRAB9ANPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 SLC22A12 4500/4885MAPT 4572/4885RAB9A 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.